explore -WSS

explore

author：knowledge 2025-10-02 19:20:11 - browse：65424

Scientific watchdogs Sholto David (right) and Elisabeth Bik join STAT's Jonathen Wosen at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.” The possibility that AI-generated, fraudulent data could be making its way into more established journals is a constant fear.

But institutions and academic journals aren’t doing enough about it, she said at the STAT breakthrough summit in San Francisco.

While artificial intelligence can be a powerful research tool when used legitimately, it’s also “absolutely frightening to me what AI can generate,” Bik said. “I’m worried this has already infiltrated scientific literature. It’s hard to tell [AI-generated images] apart from real photos. They look so real. I feel publishers are not putting [in] enough effort to deal with it — how do we find the fake photos?”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Methadone treatment changes are coming. Do they go far enough?

Wikipedia

leisure time

WSS

Maui funeral service workers on devastation of fires: 'I'm in shock'

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Virtual Event: March of the Biosimilars

Leading voice in opioid treatment defends methadone clinic system

Intermittent fasting comes with a heart risk? Not so fast

Neuroscience’s long legacy of racism

leisure time

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

ChatGPT in medicine: STAT answers readers' burning questions

Stop the failed accountable care organization experiment

Cancer drug shortages should be causing more outrage

Pharma budget tightening trickles down to Doximity

The cancer drug shortage isn’t new — and neither are the solutions

Where are patients getting their prescriptions for GLP

Psychedelics group wrestles with new pharma identity

SCOTUS questions limit to govt efforts to fight misinformation

Bright Health sells Medicare Advantage business to Molina

Orchard's therapy for neuron disease in children wins FDA approval

focus

Physicians and social media: If you see something, say something?

Health AI adoption puts security, privacy startups on investors' radar

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Readout Newsletter: Bluebird, CVS, Contineum

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Gene editing the human germline: What are the risks?

knowledge

Wikipedia

leisure time

focus